Abiopharma

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Anavexs Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III AD Trial

Larrabee Steven P. 🟡 adjusted position in 31.0K shares (1 derivative) of DuPont de Nemours, Inc. (DD) at $78.00 ($5.7M) Transaction Date: Sep 04, 2025 | Filing ID: 015434

Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference

New Form 8-K - Jade Biosciences, Inc. Filed: 2025-09-09 AccNo: 0001193125-25-198777 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Alto Neuroscience, Inc. - Alto Neuroscience Announces Robust Replication of EEG Biomarker to Objectively Identify Patients with Cognitive Impairment in Schizophrenia

Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025

Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome

New Form 8-K - HARROW, INC. Filed: 2025-09-09 AccNo: 0001493152-25-012840 Size: 297 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - HARVARD BIOSCIENCE INC Filed: 2025-09-09 AccNo: 0001171843-25-005787 Size: 244 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Castle Biosciences - New Data at American Foregut Societys 2025 Annual Meeting Demonstrates TissueCypher® Can Detect High-Risk Barrett’s Esophagus Patients Not Identified by Pathology to Support Improved Care Decisions

New Form 6-K - EDAP TMS SA Filed: 2025-09-09 AccNo: 0001171843-25-005786 Size: 8 MB

New Form 6-K - GH Research PLC Filed: 2025-09-09 AccNo: 0001140361-25-034360 Size: 434 KB